Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nucleophosmin 1 pseudogene 38 (NPM1P38) is classified as a pseudogene—an inactive genomic DNA sequence derived from the functional NPM1 gene, which encodes nucleophosmin, a multifunctional nucleolar phosphoprotein involved in ribosome biogenesis, genomic stability, and cell cycle control[5][1]. Unlike its functional counterpart, NPM1P38 does not encode a functional protein. Pseudogenes like NPM1P38 can sometimes regulate their parent gene through RNA-mediated mechanisms or antisense transcripts, but there is no evidence for specific regulatory or pathological functions assigned to NPM1P38 itself[4][5]. NPM1P38 is not considered a therapeutic target, nor is it associated with diseases or drug interactions. If you require information on the functional NPM1 protein or gene, or if you meant a different molecule, please clarify, as NPM1P38 itself is not a canonical drug target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nucleophosmin 1 pseudogene 38 (NPM1P38).